about
Sex-related differences in autoimmune-induced lung lesions in MRL/MpJ-faslpr mice are mediated by the development of mediastinal fat-associated lymphoid clusters.Degenerative and regenerative features of myofibers differ among skeletal muscles in a murine model of muscular dystrophy.Effects of a mixture of medetomidine, midazolam and butorphanol on anesthesia and blood biochemistry and the antagonizing action of atipamezole in hamsters.Comparative analysis of mediastinal fat-associated lymphoid cluster development and lung cellular infiltration in murine autoimmune disease models and the corresponding normal control strains.Female cotton rats (Sigmodon hispidus) develop chronic anemia with renal inflammation and cystic changes.Local CD34-positive capillaries decrease in mouse models of kidney disease associating with the severity of glomerular and tubulointerstitial lesions.Structural changes of goat parotid salivary gland: pre- and post-weaning periods.Genetic factors derived from the MRL/MpJ mouse function to maintain the integrity of spermatogenesis after heat exposure.Comparative protective effects of royal jelly and cod liver oil against neurotoxic impact of tartrazine on male rat pups brain.Spatiotemporal distribution of extracellular matrix changes during mouse duodenojejunal flexure formation.Autoimmune abnormality affects ovulation and oocyte-pick-up in MRL/MpJ-Fas lpr/lpr mice.IL-36α Regulates Tubulointerstitial Inflammation in the Mouse Kidney.Rapid specimen preparation to improve the throughput of electron microscopic volume imaging for three-dimensional analyses of subcellular ultrastructures with serial block-face scanning electron microscopy.Hydronephrosis with ureteritis developed in C57BL/6N mice carrying the congenic region derived from MRL/MpJ-type chromosome 11.Immunohistochemical localization of osteoblast activating peptide in the mouse kidney.Characterization of mouse mediastinal fat-associated lymphoid clusters.Morphofunctional analysis of antigen uptake mechanisms following sublingual immunotherapy with beads in mice
P50
Q38700486-91FFF625-F56D-4497-9D45-74AB7AEFA153Q39545041-23292406-FB5B-4EAF-BE32-7B73B77B72B5Q40177067-A0F9EFCC-7228-4132-A974-8C5DF31A4828Q40463664-8F921CF5-315C-46A4-81B3-57B58DC10D36Q40705644-4BE5D1A8-BF0E-4306-A8DD-E9EA160FD9F8Q41613369-0C9815C1-62BF-4755-9C1F-44A6D2E05C88Q42440963-7D8B81D3-FC62-44C4-AD3B-B48CBA71CCAAQ46447517-E363AEB8-785A-4438-B6CF-1A55D51842E2Q46536730-18D65DD6-1198-4A82-A5E8-649887B9F334Q46825813-8D04D614-3174-4338-A73B-C787BEE78771Q46940532-0FF809A3-241F-4C84-A2C5-CE701C81D1E4Q47115551-570B579E-D780-4048-992A-E3D667C1407DQ48913536-8DE88217-4D7C-456F-8D9B-37D2189AD99CQ51240109-3E6B9FFA-78A7-4DEF-A8A6-37E0216756FEQ51734246-2225AC22-4749-4DB5-B592-B68272D0CB25Q53144845-1D8CDFAA-AB57-4537-B829-E9962C568A67Q60944996-93E91EDC-1647-4103-BE98-60EDD6C3CD43
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Y H A Elewa
@en
Y H A Elewa
@nl
type
label
Y H A Elewa
@en
Y H A Elewa
@nl
prefLabel
Y H A Elewa
@en
Y H A Elewa
@nl
P31
P496
0000-0002-7347-4587